Statutory Rules 1993 No. 2701
__________________
Health Insurance (1993-1994 Pathology Services Table) Regulations
__________________
TABLE OF PROVISIONS
Regulation Page
1. Commencement 1
2. Citation 1
3. Repeal of Health Insurance (1992-1993 Pathology Services Table) Regulations 2
4. Pathology services table 2
SCHEDULE
TABLE OF PATHOLOGY SERVICES 3
PART 1—RULES OF INTERPRETATION 3
PART 2—SERVICES AND FEES 13
PART 3—ABBREVIATIONS 37
Statutory Rules 1993 No. 2701
__________________
Health Insurance (1993-1994 Pathology Services Table) Regulations
I, The Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following Regulations under the Health Insurance Act 1973.
Dated 28 October 1993.
BILL HAYDEN
Governor-General
By His Excellency’s Command,
GRAHAM RICHARDSON
Minister for Health
____________
Commencement
1. These Regulations commence on 1 November 1993.
Citation
2. These Regulations may be cited as the Health Insurance (1993-1994 Pathology Services Table) Regulations.
Repeal of Health Insurance (1992-1993 Pathology Services Table) Regulations
3. Statutory Rules 1992 No. 336 and 1993 No. 125 are repealed.
Pathology services table
4. The table of pathology services in the Schedule is prescribed for the purposes of subsection 4a (2) of the Health Insurance Act 1973.
SCHEDULE Regulation 4
TABLE OF PATHOLOGY SERVICES
PART 1—RULES OF INTERPRETATION
1. (1) In this table, unless the contrary intention appears:
“approved pathology authority” has the same meaning as in Division 4A of Part IIa of the Act;
“patient episode” means:
(a) a pathology service to which rule 3a refers that is provided in the circumstances described in that rule that relate to the service; and
(b) except in the case of a pathology service to which paragraph (a) refers—a pathology service or pathology services, whether specified in a single item or in more than 1 item, provided for a single patient whose need for the service or services was determined under subsection 16a (1) of the Act on the same day, whether rendered by an approved pathology practitioner or more than 1 approved pathology practitioner on the same day or on different days;
“recognised pathologist” means a medical practitioner recognised as a specialist in pathology by a determination under subsection 61 (3) of the Act;
“the Act” means the Health Insurance Act 1973.
(2) In these Rules, a reference to a request to an approved pathology practitioner includes a reference to a request for a pathologist-determinable service to which subsection 16a (6) of the Act applies.
(3) Unless the contrary intention appears, a reference in this table by number to an item that is not included in this table is a reference to the correspondingly numbered item in the general medical services table or the diagnostic imaging services table, as each case requires.
2. (1) If a service is described:
(a) in an item in general terms; and
(b) in another item in specific terms:
only the item that describes the service in specific terms applies to the service.
(2) Subject to subrule (3), if:
(a) a service is described in 2 or more items; and
(b) subrule (1) does not apply;
only the item that provides the lower or lowest fee for the service applies to the service.
(3) If an item is expressed to include a pathology service that is specified in another item, the other item does not apply to the service in addition to the first-mentioned item.
3. (1) In subrule (2), “service” includes assay, estimation and test.
(2) Subject to rule 3a, 2 or more pathology services rendered for a patient following 2 or more requests are taken to have been rendered following a single request if:
(a) the services are listed in the same item; and
(b) the patient’s need for the services was determined under subsection 16a (1) of the Act on the same day even if they are rendered by an approved pathology practitioner on more than one day.
3a. (1) Rule 3 does not apply to:
(a) a pathology service specified in item 66201, other than an estimation of fructosamine or lithium; or
(b) the quantitative estimation of 1 or more fractions of neonatal bilirubin specified in item 66365;
if:
(c) the service is rendered in relation to a single specimen taken on each of not more than 4 occasions in a period of 24 hours; and
(d) the service is rendered to a patient in a hospital unit where:
(i) the presence of 1 nurse is required for each group of not more than 4 patients; and
(ii) the condition of the patients is continuously observed in relevant respects; and
(e) in order to render the service, an approved pathology practitioner who is a recognised pathologist has to arrange for a member of the laboratory staff of the approved pathology authority concerned to undertake duties in respect of the service that are in addition to the usual duties of the staff member.
(2) Rule 3 does not apply to any of the following pathology services if, under a request for a service, no more than 6 tests are requested and the tests are performed within 6 months of the request:
(a) estimation of prothrombin time in respect of a patient undergoing anticoagulant therapy;
(b) quantitative estimation of lithium in respect of a patient undergoing lithium therapy;
(c) a service specified in item 65007 in relation to a patient undergoing chemotherapy for neoplastic disease or immunosuppressant therapy;
(d) a service specified in item 65007 in relation to methotrexate, gold or penicillamine therapy of a patient;
(e) a service specified in item 66201 in relation to methotrexate therapy of a patient;
(f) quantitative estimation of urea, creatinine and electrolytes in relation to:
(i) cis-platinum therapy of a patient; or
(ii) chronic renal failure of a patient being treated in a dialysis program conducted by a recognised hospital.
(2a) Rule 3 does not apply to a pathology service:
(a) to which item 66217 applies; and
(b) for which a specimen is collected on each of 3 days for the purpose of making a valid estimation.
(3) This rule does not apply in relation to a pathology service unless the account for fees in respect of the service is endorsed with the words “Rule 3 Exemption”.
4. If:
(a) a pathology service to which an item of the table applies is rendered for a patient in accordance with a request; and
(b) another pathology service is rendered for the patient in accordance with the request; and
(c) an item of the table:
(i) applies to the other service; and
(ii) is referred to in the item mentioned in paragraph (a);
the other service is treated as if it were part of the service referred to in paragraph (a).
Example:
The requesting practitioner requests an extended blood grouping test (covered by item 65019) and the test includes a basic blood grouping test (covered by item 65017). Item 65017 is referred to in item 65019. Benefit is payable under item 65019 for the extended blood grouping test but benefit is not payable separately under item 65017 for the basic blood grouping test.
5. For the purposes of items 65001 to 66200 (inclusive):
(a) if pathology services of a kind referred to in item 65017 or 65019 are rendered for a patient during a period when the patient is in hospital, the item applies only to the first pathology service of that kind rendered for the patient during that period; and
(b) tests (except the tests mentioned in item 65023) carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.
5a. (1) In this rule:
“designated pathology service” means a pathology service specified in item 66241, 66389, 66403 or 69241.
(2) Subject to subrule (3), if an approved pathology practitioner in an approved pathology authority:
(a) has been requested to render a pathology service that specified 2 or more estimations comprising a designated pathology service; and
(b) is unable to perform 1 or more, but not all, of the estimations because of the lack of facilities in, or expertise or experience of the staff of, the laboratory of the authority in relation to that estimation or those estimations; and
(c) requests an approved pathology practitioner in another approved pathology authority to render 1 or more, but not all, of the estimations;
the service rendered by the second-mentioned practitioner is taken to be the designated pathology service.
(3) Items 73901 to 73917 (inclusive) do not apply to the second-mentioned approved pathology practitioner in subrule (2).
6. For the purposes of items 66201 to 69200 (inclusive):
(a) if a pathology service involving the measurement of a substance in urine requires a 24 hour urine collection, or calculation of a substance/creatinine ratio, the service is treated as including any estimation of creatinine in other fluids necessary for the calculation; and
(b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.
7. For the purposes of items 69201 to 71000 (inclusive):
(a) “serial examinations or cultures” means examinations or cultures requested on 1 occasion whether or not;
(i) the materials are received on different days by the approved pathology practitioner; or
(ii) the examinations or cultures were requested on 1 or more request forms by the treating practitioner; and
(b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.
8. For the purposes of items 71001 to 72800 (inclusive):
(a) in items 71119, 71121, 71123 and 71125, the estimation of a single antibody includes qualitative and quantitative assays for that antibody; and
(b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.
9. For the purposes of items 72801 to 73040 (inclusive):
(a) “biopsy material” means all tissue received by the approved pathology practitioner from an operation, or a group of operations, performed on a patient at the same time, other than a bone marrow biopsy; and
(b) if:
(i) a pathology service that is the examination of biopsy material is rendered under any of those items; and
(ii) a further pathology service mentioned in any of those items is also rendered using that biopsy material;
those pathology services are treated as 1 pathology service.
10. For the purposes of items 73041 to 73280 (inclusive), “serial examinations” means examinations requested on 1 occasion whether or not:
(a) the materials are received on different days by the approved pathology practitioner; or
(b) the examinations were requested on 1 or more request forms by the treating practitioner.
11. (1) For the purposes of this rule and items 73901 to 73921 (inclusive):
“institution” means a place (other than a hospital, a nursing home or accommodation for aged persons that is attached to a nursing home or situated within a nursing home complex) at which residential accommodation or day care is, or both residential accommodation and day care are, made available to:
(a) disadvantaged children; or
(b) juvenile offenders; or
(c) aged persons; or
(d) chronically ill psychiatric patients; or
(e) homeless persons; or
(f) unemployed persons; or
(g) persons suffering from alcoholism; or
(h) persons addicted to drugs; or
(i) physically or mentally handicapped persons;
“licensed collection centre” has the same meaning as in Part IIa of the Act;
“prescribed laboratory” means a laboratory operated by:
(a) the Commonwealth; or
(b) a State; or
(c) an authority of a State or Territory; or
(d) the Northern Territory; or
(e) the Australian Capital Territory; or
(f) an Australian tertiary education institution.
“specimen collection centre” has the same meaning as in Part IIa of the Act;
“temporary collection centre” has the same meaning as in Part IIa of the Act;
“treating practitioner” has the same meaning as in paragraph 16a (1) (a) of the Act.
(2) A service mentioned in items 73901 to 73921 (inclusive) applies to a pathology service when rendered by, or on behalf of, an approved pathology practitioner who is a recognised pathologist unless:
(a) the service is rendered upon a request made in the course of an out-patient service at a recognised hospital; or
(b) the service is rendered upon a request made for a patient who is a private patient in a recognised hospital when the request was made; or
(c) the pathology equipment of a recognised hospital, or prescribed laboratory, is used rendering the service; or
(d) a member of the staff of a recognised hospital, or prescribed laboratory, participates in the service in the course of the member’s employment with the hospital or laboratory.
(3) A service mentioned in items 73901 to 73921 (inclusive) does not apply to a pathology service:
(a) to which subsection 16a (7) of the Act applies; or
(b) unless at least one of items 65001 to 73529 (inclusive) also applies to that service.
(4) Subject to subrule (6), if one item of items 73901 to 73917 (inclusive) applies to a patient episode, none of the remainder of those items applies to that patient episode.
(5) Item 73921 applies only to the approved pathology practitioner or approved pathology authority to whom the specimen mentioned in the item was referred.
(6) If, in respect of the same patient episode:
(a) services referred to in 1 or more items:
(i) in Group P5; and
(ii) in one of Groups P1, P2, P3, P4, P6, P7 and P8; or
(b) services referred to in 1 or more items:
(i) in Group P6; and
(ii) in one of Groups P1, P2, P3, P4, P5, P7 and P8;
are rendered by an approved pathology practitioner in each of 2 approved pathology authorities, the applicable amount specified in an item in Group P10 is payable to both approved pathology practitioners.
(7) If more than one specimen is collected from a person on the same day for the provision of pathology services:
(a) in accordance with more than one request; and
(b) in or by a single approved pathology authority;
only a single amount specified in the applicable item in Group P10 is payable for the services.
11a. If item 73921 applies to a patient episode, none of items 73901 to 73917 (inclusive) applies to any pathology service rendered by the approved pathology authority or the approved pathology provider in respect of that patient episode.
11b. (1) Item 73921 does not apply to a referral if:
(a) a service in respect of the same patient episode has been carried out by the referring approved pathology authority; and
(b) the approved pathology authority to which the referral is made is related to the referring approved pathology authority.
(2) An approved pathology authority is related to another approved pathology authority for the purposes of subclause (1) if:
(a) both approved pathology authorities are employed (including employed under contract) by the same person, whether or not that person is also an approved pathology authority; or
(b) either of the approved pathology authorities is employed (including employed under contract) by the other; or
(c) if both of the approved pathology authorities are corporations—the approved pathology authorities are related corporations within the meaning of the Corporations Law; or
(d) the approved pathology authorities are partners (whether or not either or both of the approved pathology authorities are individuals and whether or not other persons are in partnership with either or both of the approved pathology authorities).
12. The abbreviations in Part 3 of this table may be used to identify particular pathology services or groups of pathology services.
SCHEDULE—continued
PART 2—SERVICES AND FEES
GROUP P1—HAEMATOLOGY
Item number
Pathology service
Fee
$
65001
Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count—1 or 2 procedures
5.60
65003
3 or more procedures to which item 65001 applies, including any calculation or measurement of erythrocyte or other indices
7.65
65005
Examination of blood film, with or without 5 part differential cell count, or 5 part differential cell count with or without examination of blood film, and, if performed, any of these additional services—
Direct Coombs test; tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitroblue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 65027
10.10
65007
Full blood examination consisting of items 65003 and 65005
17.50
65009
Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by—erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine—1 or more procedures
23.30
65011
Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and 2 of the following—examination for HbH, quantitation of HbA2 or HbF—including any services specified in items 65001, 65003, 65005 and 65007
36.30
65013
Histopathological examination of sections of bone marrow trephine biopsy including, where indicated, examination of marrow smears and any special stains and immunochemical techniques, including any services specified in items 65001, 65003, 65005, 65007 and 65015
111.50
65015
Bone marrow examination of aspirated material including any special stains, immunochemical techniques and clot sections where necessary, including any services specified in items 65001, 65003, 65005 and 65007
80.95
65017
Blood grouping, including back-grouping when performed—ABO and Rh (D antigen)
9.80
65019
Blood grouping—Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system—1 or more systems, including any services specified in item 65017
19.50
65021
Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 65001, 65003, 65005 and 65007
36.30
65023
Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 65001, 65003, 65005, 65007, 65017 and 65021 including all testing performed on any 1 day
88.60
65025
Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected
16.05
65027
Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm’s test) including those services specified in items 65005 and 65007—1 or more tests
8.85
65029
Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 of: fibrinogen degradation products, fibrin monomer or D-dimer—1 estimation
12.25
65031
2 estimations specified in item 65029
16.20
65033
3 estimations specified in item 65029
20.15
65035
4 or more estimations specified in item 65029
24.10
65037
Quantitative assay, by 1 or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin cofactor II, euglobulin clot lysis time and test for lupus anticoagulant—1 estimation
24.05
65039
4 or more estimations specified in item 65037
76.40
65041
Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance—1 or more estimations
48.10
65043
Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin —1 or more estimations
32.10
65045
Quantitative assay of:
Von Willebrand’s factor antigen (factor VIII related antigen), Von Willebrand’s factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor—1 estimation
32.05
65047
2 estimations as specified in item 65045
46.20
65049
3 or more estimations as specified in item 65045
60.35
GROUP P2—CHEMICAL
66201
Quantitative estimation in serum, plasma, urine or other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis, of:—
alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate, urea—1 estimation
9.90
66203
2 estimations specified in item 66201
11.95
66205
3 estimations specified in item 66201
14.00
66207
4 estimations specified in item 66201
16.05
66209
5 estimations specified in item 66201
18.10
66211
6 or more estimations specified in item 66201
20.15
66213
Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents:
bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma—1 or more estimations
9.60
66215
Quantitative estimation of cryoglobulins or cryofibrinogen after a positive result for cryoglobulin is obtained in any service specified in item 66213 (including provision of that service)—1 or more estimations
14.50
66217
Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents—
haemoglobin, porphyrins, reducing substances—each estimation, to a maximum of 3 estimations, taken on separate days
6.40
66219
Immunological detection of human haemoglobin in faeces, including any additional services specified in item 66217—1 estimation in any 28 day period
12.20
66223
Osmolality, estimation by osmometer, in serum or in urine—1 or more estimations
24.05
66225
Quantitative estimation of blood gases including tests performed from pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen—1 or more estimations on 1 specimen
32.85
66227
Estimation of blood gases as specified in item 66225 on each specimen in excess of 1 to a maximum of 6 specimens within any 1 day
8.70
66229
Calculus, analysis of 1 or more
29.80
66231
Drug or chemical assays—including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235, 66237 and 66239, but excluding the surveillance of sports people and athletes for performance improving substances or the monitoring of patients participating in a drug abuse treatment program
40.50
66235
Drug assay—quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule—1 estimation
20.20
66237
2 estimations specified in item 66235
28.30
66239
3 or more estimations specified in item 66235
36.40
66241
Estimations specified in any of items 66235 to 66239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 3—each estimation to a maximum of 2 estimations
8.10
66243
Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid—1 or more examinations or estimations
32.10
66245
Electrophoresis, quantitative or qualitative, of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the cholesterol is >6.5 mmol/l and triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidaemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity—1 examination to a maximum of 2 examinations in any 12 month period
29.80
66247
Electrophoresis, quantitative or qualitative, of concurrently collected, or collected within a 28 day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin, or of total relevant enzyme activity—2 or more examinations
44.30
66255
Alpha-1-acid glycoprotein, alpha-1-antitrypsin, alpha-2-macroglobulin, quantitative estimation in serum, urine or other body fluid—1 or more estimations
19.65
66257
C-1 esterase inhibitor, quantitative estimation
19.65
66258
C-1 esterase inhibitor, functional assay
43.95
66261
CA-125 antigen, CA-15.3 antigen, CA-19.9 antigen, carcinoembryonic antigen (CEA), mammary serum antigen, mucin-like carcinoma associated antigen (1 or more fractions), neuron-specific enolase, thyroglobulin in serum or other body fluid, in the monitoring or confirmation of malignancy, quantitative estimation—1 estimation
19.65
66262
2 or more estimations specified in item 66261
36.20
66263
Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin
38.20
66265
Serum B12, serum folate—1 or more estimations within any 28 day period
24.05
66267
Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 estimations in any 12 month period
43.90
66269
Vitamins , quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of vitamins A, B1, B2, B3, B6, C, and E—1 or more estimations within any 6 month period
29.80
66271
Vitamin D or D fractions—1 or more estimations
29.80
66277
Aluminium (except if item 66325 applies), arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium, in blood, urine or other body fluid or tissue—1 or more estimations in any 6 month period
34.90
66279
Blood lead estimation, other than for occupational health screening purposes, to a maximum of 3 estimations in any 6 month period—each estimation
29.80
66281
Porphyrins (1 or more fractions), catecholamines (1 or more fractions), hydroxymethoxymandelic acid (HMMA), homovanillic acid (HVA), metanephrines, methoxyhydroxyphenylethylene glycol (MHPG), phenylacetic acid (PAA)—quantitative including any qualitative estimations—1 or more estimations
38.95
66283
Faecal fat, breath hydrogen measurements in response to loading with disaccharides—1 or more quantitative estimations within any 28 day period
38.95
66285
Solid tissue or tissues excluding blood elements—assay of 1 or 2 enzymes
38.95
66287
Assay of 3 to 5 enzymes as specified in item 66285
72.55
66289
Assay of 6 or more enzymes as specified in item 66285
96.25
66291
Thyroid function tests, including thyrotrophin (TSH) and at least 1 or more of the following tests—free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin
40.50
66293
Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones
48.10
66295
Growth hormone suppression by glucose loading, growth hormone stimulation by exercise, dexamethasone suppression test, L-dopa stimulation of growth hormone, where physically performed by a recognised pathologist—1 or more procedures
11.45
66297
Gonadotrophin releasing hormone stimulation test, synacthen stimulation test, glucagon stimulation test with C-peptide measurement, pentagastrin stimulation of thyrocalcitonin release, secretin stimulation of gastrin release, insulin hypoglycaemia, arginine infusion, where physically performed by a recognised pathologist—1 procedure
38.20
66299
2 or more tests specified in item 66297
61.10
66315
Hormone receptor assay on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast—1 or more assays
77.90
66317
HDL cholesterol or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5 mmol/1 or those on prescribed lipid lowering drugs or with a fasting serum triglyceride level >2.0 mmol/1—each episode to a maximum of 4 episodes in any 12 month period
12.20
66319
Glycosylated haemoglobin only when performed in the management of established diabetes—each estimation to a maximum of 4 estimations in any 12 month period
16.40
66321
Quantitative estimation in the 2nd trimester of pregnancy of alpha fetoprotein, human chorionic gonadotrophin and oestriol and any other substance to detect foetal abnormality, including any service specified in 1 or more of items 66353, 66373, 73527 or 73529—1 patient episode in that pregnancy
53.80
66323
Estimation of tryptic activity in faeces for the investigation of diarrhoea of greater than 4 weeks duration in children less than 6 years of age
10.85
66325
Estimation of serum aluminium in a patient in a renal dialysis program—each estimation
34.90
66331
Quantitative estimation in serum, plasma, urine or other body fluid of cholesterol or triglycerides or both, except by reagent strip with or without reflectance meter or electrophoresis
11.75
66335
Services specified in item 66331 and 1 estimation specified in item 66201
14.00
66337
Services specified in item 66331 and 2 estimations specified in item 66201
16.05
66339
Services specified in item 66331 and 3 estimations specified in item 66201
18.10
66341
Services specified in item 66331 and 4 or more estimations specified in item 66201
20.15
66343
Drug assays, including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient participating in a drug abuse treatment program, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programs—each assay to a maximum of 21 assays in any 12 month period
20.25
66353
Alpha fetoprotein (where not requested as part of item 66321)—quantitative estimation in serum or other body fluids
19.65
66355
Ferritin (where not requested as part of iron studies)—quantitative estimation
19.65
66357
Prostate specific antigen, prostatic acid phosphatase, in the monitoring or confirmation of malignancy—quantitative estimation—1 estimation
19.65
66359
2 estimations specified in item 66357
36.20
66361
Beta-2-microglobulin, caeruloplasmin, haptoglobulins, microalbumin in proven diabetes mellitus, prealbumin—quantitative estimation in serum, urine or other body fluids—1 estimation
19.65
66363
2 or more estimations specified in item 66361
36.20
66365
Neonatal bilirubin (1 or more fractions)—quantitative estimation
24.05
66367
Acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, beta-hydroxybutyrate, cholinesterase, cysteine, total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, oxalate, pyruvate, serotonin, xylose, zinc—1 quantitative estimation
24.05
66369
2 or more estimations specified in item 66367
37.80
66371
TSH (where not requested as part of thyroid function test or in association with other hormones or hormone binding proteins specified in item 66377)—quantitative estimation
31.15
66373
Human placental lactogen, oestriol (where not requested as part of item 66321)—quantitative estimation by any method—1 estimation
31.15
66375
2 estimations specified in item 66373
42.05
66377
Hormones and hormone binding proteins, quantitative estimation by any method, of—androstenedione, DHEAS, dihydrotestosterone, FSH, hydroxyprogesterone, LH, oestradiol, oestrone, progesterone, prolactin, sex hormone binding globulin, free or total testosterone, TSH (where it is not requested on its own or as part of a thyroid function test)—1 estimation
31.15
66379
2 estimations specified in item 66377
42.05
66381
3 estimations specified in item 66377
52.95
66383
4 estimations specified in item 66377
63.85
66385
5 estimations specified in item 66377
74.75
66387
6 or more estimations specified in item 66377
85.65
66389
Estimations specified in any of items 66377 to 66387 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6—each estimation to a maximum of 5 estimations
10.90
66391
Hormones and hormone binding proteins, quantitative estimation by any method, of: ACTH, aldosterone, C-peptide, calcitonin, cortisol, cyclic AMP, 11-deoxycortisol, gastrin, glucagon, growth hormone, insulin, PTH, renin, somatomedin C(IgF1), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (anti-diuretic hormone)—1 estimation
31.15
66393
2 estimations specified in item 66391
42.05
66395
3 estimations specified in item 66391
52.95
66397
4 estimations specified in item 66391
63.85
66399
5 estimations specified in item 66391
74.75
66401
6 or more estimations specified in item 66391
85.65
66403
Estimations specified in any of items 66391 to 66401 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6—each estimation to a maximum of 5 estimations
10.90
GROUP P3—MICROBIOLOGY
69201
Microscopic examination of material other than blood, from 1 or more sites, obtained directly from a patient and excluding material from cultures—wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains—1 or more examinations
7.25
69203
Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of 3 estimations taken on separate days including any services specified in item 69201—each estimation
12.20
69205
The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201—1 or more sites
19.10
69207
Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites: skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201, 69205 and 73810—1 or more examinations on 1 or more specimens
27.90
69209
Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of postoperative wounds, aspirations of body cavities, synovial fluid, CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201, 69205 and 69207—1 or more sites
37.80
69211
Cultural examination (including the detection of clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least 2 selective or enrichment media as well as culture in at least 2 different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201, to a maximum of 3 specimens in any 7 day period—each examination
45.85
69213
Microscopy with appropriate stains and cultural examinations of 3 specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 69201
64.15
69215
Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing —each set of cultures to a maximum of 3 sets
16.80
69217
Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts (simple culture by dip slide is excluded from this item)
20.30
69219
Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 69211 has been performed—1 or more estimations
16.05
69221
Direct detection of Chlamydia from clinical material, not cultures—1 or more estimations
9.60
69223
Direct detection of herpes simplex virus from clinical material, not cultures—1 or more estimations
9.60
69229
Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule—estimation of 1 antibody
13.75
69231
2 estimations specified in item 69229
21.05
69233
3 estimations specified in item 69229
28.35
69235
4 estimations specified in item 69229
35.65
69237
5 estimations specified in item 69229
42.95
69239
6 or more estimations specified in item 69229
50.25
69241
Estimations specified in any of items 69229 to 69239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6—each estimation to a maximum of 5 estimations
7.30
69243
Hepatitis B surface antigen test
13.60
69245
Hepatitis B serology to define the immune status of an individual, including at least hepatitis B surface antibody or hepatitis B core antibody tests, including services specified in items 69243, 69247 and 69249
18.35
69247
All serological tests performed for the identification of the agent causing acute hepatitis, which must include hepatitis B surface antigen, hepatitis B core antibody and hepatitis A IgM antibody tests and those services specified in items 69243, 69245 and 69249
36.30
69249
All tests performed in the follow-up of a patient with proven hepatitis B, including hepatitis B surface antigen and either hepatitis B antigen or hepatitis B surface antibody tests, including services specified in items 69243 and 69245
26.35
69251
Antibiotics or antimicrobial chemotherapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent—1 or more estimations
24.05
69253
All microbiological serology during a pregnancy, which must include the determination of 1 of the following—rubella immune status, specific syphilis serology or hepatitis B surface antigen, including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy
13.75
69255
All microbiological serology during a pregnancy, which must include the determination of 2 of the following—rubella immune status, specific syphilis serology or hepatitis B surface antigen and including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy
21.00
69257
All microbiological serology during a pregnancy, which must include the determination of all 3 of the following—rubella immune status, specific syphilis serology and hepatitis B surface antigen, including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy
27.90
69261
Examination for chlamydia by culture or by the demonstration of chlamydial nucleic acid using a DNA probe in material collected directly from a patient, including a service specified in item 69221, 69223 or 69263
17.80
69263
Examination for herpes simplex virus of one or more types in material collected directly from a patient by culture, including a service specified in item 69221, 69223 or 69261
27.80
69265
Determination of antibodies to hepatitis C
13.75
GROUP P4—IMMUNOLOGY
71061
Examination for, and characterisation of, a paraprotein or cryoglobulin not previously characterised on serum, urine or other body fluid by immunoelectrophoresis or immunofixation—1 or more procedures
28.45
71063
Examination for, and characterisation of, a paraprotein not previously characterised, by immunoelectrophoresis or immunofixation on serum and urine collected concurrently—2 or more procedures
42.90
71065
Examination of CSF and serum concurrently for the presence of oligoclonal proteins—2 or more procedures
42.90
71067
Immunoglobulins A, G, M or D, quantitative estimation by any method in serum, urine or other body fluid—1 estimation
14.65
71069
2 estimations as specified in item 71067
23.15
71071
3 or more estimations as specified in item 71067
31.65
71073
Immunoglobulin G subclasses, quantitative estimation of all 4 subclasses with a maximum of 2 patient episodes in any 12 month period—each patient episode
103.45
71075
Immunoglobulin E (total), quantitative estimation with a maximum of 2 patient episodes in any 12 month period—each patient episode
26.35
71077
Immunoglobulin E (total), quantitative estimation in the follow-up of a patient with proven immunoglobulin E secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, with a maximum of 6 patient episodes in any 12 month period—each patient episode
26.35
71079
Estimation of specific immunoglobulin G or E antibodies to single or multiple potential allergens, with a maximum of 4 patient episodes in any 12 month period—each patient episode
23.80
71081
Total haemolytic complement, quantitative estimation
19.65
71083
Complement components C3, C4 or properdin factor B, quantitative estimation—1 estimation
19.65
71085
2 estimations as specified in item 71083
28.20
71087
3 or more estimations as specified in item 71083
36.80
71089
Complement components or breakdown products of complement proteins not elsewhere specified in an item in this Schedule, quantitative estimation—1 estimation
28.40
71091
2 estimations as specified in item 71089
51.45
71093
3 or more estimations as specified in item 71089
74.50
71097
Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required
24.80
71099
Double-stranded DNA antibodies, quantitative estimation by 1 or more methods other than the Crithidia method
25.85
71101
Antibodies to 1 or more extractable nuclear antigens, detection in serum or other body fluids
16.95
71103
Antibodies to 1 or more extractable nuclear antigens, characterisation after a positive result is obtained by a service specified in item 71101, including that service
50.70
71105
Rheumatoid factor, detection by any technique
8.50
71107
Quantitation of rheumatoid factor if detected during a service specified in item 71105, including that service
19.65
71109
Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, glomerular basement membrane, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, neutrophil cytoplasm, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome, thyroid stimulating hormone receptor), qualitative or quantitative—estimation of 1 antibody
33.65
71113
Estimation of 2 antibodies specified in item 71109
46.20
71115
Estimation of 3 antibodies specified in item 71109
58.75
71117
Estimation of 4 antibodies specified in item 71109
71.30
71119
Antibodies to tissue antigens not elsewhere specified in an item in this Schedule, qualitative or quantitative—estimation of 1 antibody
16.90
71121
Estimation of 2 antibodies specified in item 71119
20.25
71123
Estimation of 3 antibodies specified in item 71119
23.60
71125
Estimation of 4 or more antibodies specified in item 71119
26.95
71127
Functional tests for lymphocytes—estimation of proliferation induced by 1 or more mitogens, estimation of proliferation induced by 1 or more antigens or estimation of 1 or more mixed lymphocyte reactions, other than quantitation by microscopy, including a test specified in item 65005, with a maximum of 2 patient episodes in any 12 month period—each patient episode
171.85
71129
2 estimations specified in item 71127
212.30
71131
3 or more estimations specified in item 71127
252.75
71135
Determination of neutrophil function—comprising at least 2 of neutrophil chemotaxis, neutrophil phagocytosis, neutrophil oxidative metabolism, neutrophil bactericidal activity—including any test specified in item 65005 (other than nitroblue tetrazolium reduction slide test), with a maximum of 2 patient episodes in any 12 month period—each patient episode
202.70
71137
Determination of cell mediated immunity by multiple antigen delayed type hypersensitivity intradermal skin testing using a minimum of 7 antigens, with a maximum of 2 patient episodes in any 12 month period—each patient episode
29.50
71139
Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 or more specimens of blood, CSF or serous fluid
101.35
71141
Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 or more disaggregated tissue specimens
222.35
71143
Characterisation (not monitoring) of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations in an immunological or haematological malignancy, including any service specified in 1 or more of items 71139 or 71141, on a specimen of blood, CSF, serous fluid or disaggregated tissue
253.40
71145
Characterisation (not monitoring) of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations in an immunological or haematological malignancy, including any service specified in 1 or more of items 71139, 71141 or 71143, on 2 or more specimens of disaggregated tissues or 1 specimen of disaggregated tissue and 1 or more specimens of blood, CSF or serous fluid
413.70
71147
HLA-B27 typing
33.60
71149
Complete tissue typing for 4 HLA-A and HLA-B Class I antigens (including any separation of leucocytes), including any service specified in item 71147
105.50
71151
Tissue typing for HLA-DR, HLA-DP and HLA-DQ Class II antigens (including any separation of leucocytes)—phenotyping or genotyping of 2 or more antigens
115.85
GROUP P5—HISTOPATHOLOGY
72801
Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions
78.05
72803
Immediate frozen section diagnosis of biopsy material, including any other histopathology examination
126.80
72805
Immunohistochemical investigation of biopsy material by 1 or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination
96.25
72807
Electron microscopy of biopsy material including any other histopathology examination
102.35
GROUP P6—CYTOPATHOLOGY
73043
Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of precancerous or cancerous changes—1 or more examinations
14.80
73045
Cytological examination, other than an examination mentioned in item 73053, for malignancy, including serial examinations and histological services performed on the resulting specimens from washings or brushings from sites not specified in item 73043, or performed on a single specimen of sputum or urine or on 1 or more specimens of other body fluids—1 or more examinations
29.00
73047
Cytological examination including examination of a series of 3 sputum or urine specimens for malignant cells
60.35
73049
Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues
36.30
73051
Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance
68.00
73053
Routine cytological examination of smears from cervix for detection of precancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia and smears repeated due to an unsatisfactory routine smear—each examination
12.40
73055
Cytological examination of smears from cervix in association with the management of previously detected abnormalities including precancerous or cancerous conditions, or the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia, not associated with item 73053—each examination
12.40
73057
Cytological examination of smears from vagina, not associated with items 73053 or 73055—each examination
12.40
GROUP P7—CYTOGENETICS
73287
Chromosome studies, including preparation, count, karyotyping and identification by banding techniques or by fragile X-site determination of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid except blood—1 or more estimations
323.50
73289
Chromosome studies, including preparation, count, karyotyping and identification by banding techniques or by fragile X-site determination of blood—1 or more estimations
293.15
GROUP P8—INFERTILITY AND PREGNANCY TESTS
73521
Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner’s test)
6.70
73523
Semen examination (excluding post vasectomy semen examination), involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and 1 or more chemical tests, with a maximum of 4 examinations in any 12 month period
27.90
73525
Sperm antibodies, sperm penetrating ability—1 or more tests
17.95
73527
Chorionic gonadotrophin (beta-HCG), qualitative estimation in serum or urine by 1 or more methods, including serial dilution if performed, for diagnosis of pregnancy —1 or more estimations
9.80
73529
Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCG-secreting neoplasm, threatened abortion or follow up of abortion
27.90
GROUP P9—SIMPLE BASIC PATHOLOGY TESTS
73801
Seminal examination for presence of spermatozoa
6.40
73802
Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin estimation, haematocrit estimation or erythrocyte count—1 procedure
4.25
73803
2 procedures specified in item 73802
5.60
73804
3 or more procedures specified in item 73802
7.65
73805
Urine—microscopical examination of, or catalase test for, bacteria and cells, whether stained or not
4.25
73806
Pregnancy test by 1 or more immunochemical methods
10.45
73807
Microscopical examination of wet film other than urine, including any relevant stain
6.40
73808
Microscopical examination of Gram stained film, including any examination specified in items 73805 and 73807
8.05
73809
Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method
2.15
73810
Microscopical examination screening for fungi in skin, hair or nails—1 or more sites
6.40
73811
Mantoux test
10.45
GROUP P10—PATIENT EPISODE INITIATION
73901
Initiation of a patient episode which consists only of a service specified in item 73053, 73055 or 73057 from a person who is not in a recognised hospital or a prescribed laboratory
7.75
73903
Initiation of a patient episode which consists only of a service specified in item 72801 from a person who is an in-patient of a hospital other than a recognised hospital
13.95
73905
Initiation of a patient episode which consists only of a service specified in item 72801 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital
7.75
73907
Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a licensed collection centre other than a temporary licensed collection centre
16.05
73909
Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital
16.05
73911
Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority, from a person in the place where the person was residing or in a nursing home or institution
16.05
73913
Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905, 73907, 73917 and 73801 to 73811 (inclusive) where the specimen is collected from the person by the person
9.85
73915
Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by or on behalf of the treating practitioner
9.85
73917
Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a temporary licensed collection centre
9.85
GROUP P11—SPECIMEN REFERRED
73921
Referral of specimen by an approved pathology practitioner of an approved pathology authority to another approved pathology practitioner of another approved pathology authority or to another approved pathology authority
9.85
PART 3—ABBREVIATIONS
A—ABBREVIATIONS FOR GROUPS OF TESTS
Group
Estimations included in group
Abbreviation
Item numbers
Cardiac Enzymes
Lactate dehydrogenase (LDH) aspartate aminotransferase (AST) and creatine kinase (CK)
CE
66205
Coagulation Studies
Prothrombin time, activated partial thrombo-plastin time and two or more of the following tests—bleeding time, thrombin clotting time, fibrinogen degradation products, fibrin monomer, D-dimer, factor XIII screening tests
COAG
65035
Electrolytes
Sodium (NA) potassium (K) chloride (CL) and bicarbonate (HCO3)
E
66207
Lipid Studies
Cholesterol (CHOL) and triglycerides (TRIG)
FATS
66331
Liver Function Tests
Alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB), bilirubin (BIL), gamma glutamyl transpeptidase (GGT), lactate dehydrogenase (LDH), and protein (PROT)
LFT
66211
Syphilis Serology
Rapid plasma reagin test (RPR) or venereal disease research laboratory test (VDRL) and treponema pallidum haemagglutination test (TPHA) or fluorescent treponemal antibody-absorption test (FTA)
STS
69231
Urea, Electrolytes, Creatine
Urea, electrolytes, creatinine
U&E
66211
B—ABBREVIATIONS FOR INDIVIDUAL TESTS
Abnormal haemoglobins AH 65027
Acetoacetate ACAT 66367
Acetylcholine receptor—tissue antigens—antibodies ARA 71109
Actinomycetes—microbial antibody testing ACT 69229
Adenovirus—microbial antibody testing ADE 69229
Adrenal cortex—tissue antigens—antibodies ADR 71109
Adrenocorticotrophic hormone (ACTH) ACTH 66391
AFB microscopy and culture of sputum AFB 69213
Alanine aminotransferase ALT 66201
Albumin ALB 66201
Alcohol (ethanol) ETOH 66367
Aldosterone ALDS 66391
Alkaline phosphatase ALP 66201
Alkaline phosphatase—isoenzymes ALPI 66245
Alpha fetoprotein AFP 66353
Alpha fetoprotein—for Down syndrome/neural tube defect testing NTDD 66321
Alpha‑1‑acid glycoprotein AAG 66255
Alpha-1-antitrypsin AAT 66255
Alpha‑2‑macroglobulin AMG 66255
Aluminium AL 66277
Aluminium—renal dialysis ALR 66325
Amino acids AA 66367
Amiodarone AMIO 66235
Amitriptyline AMIT 66235
Ammonia NH3 66367
Amniotic fluid examination AFE 66243
Amylase AMS 66201
Amylobarb AMYL 66235
Androstenedione ANDR 66377
Angiotensin converting enzyme ACE 66367
Antibiotic and antimicrobial chemotherapeutic agents—quantitative assay QAA 69251
Antibodies to—extractable nuclear antigens—detection ENA 71101
Antibodies to—extractable nuclear antigens—characterisation of antibodies if positive ENA ENAP 71103
Antibodies to—nuclear antigens—detection ANA 71097
Antibodies to—nuclear antigens—quantitation and measurement of DNA binding if positive ANA ANAP 71099
Antibodies to—tissue antigens—acetylcholine receptor ARA 71109
Antibodies to—tissue antigens—adrenal cortex ADR 71109
Antibodies to—tissue antigens—cardiolipin ACL 71109
Antibodies to—tissue antigens—centromere ACA 71119
Antibodies to—tissue antigens—gastric parietal cell PCA 71119
Antibodies to—tissue antigens—gliadin IgA GLIA 71119
Antibodies to—tissue antigens—glomerular basement membrane GBA 71109
Antibodies to—tissue antigens—heart AHE 71109
Antibodies to—tissue antigens—histone AHI 71109
Antibodies to—tissue antigens—insulin receptor antibodies INSA 71109
Antibodies to—tissue antigens—intercellular cement substance of skin ICCS 71109
Antibodies to—tissue antigens—intrinsic factor AIF 71109
Antibodies to—tissue antigens—islet cell AIC 71109
Antibodies to—tissue antigens—Jo‑1 JO1 71119
Antibodies to—tissue antigens—keratin KERA 71119
Antibodies to—tissue antigens—liver/kidney microsomes LKA 71119
Antibodies to—tissue antigens—lymphocyte ALY 71109
Antibodies to—tissue antigens—mitochondria MA 71119
Antibodies to—tissue antigens—neuron ANE 71109
Antibodies to—tissue antigens—neutrophil cytoplasm ANCA 71109
Antibodies to—tissue antigens—ovary AOV 71109
Antibodies to—tissue antigens—parathyroid PTHA 71109
Antibodies to—tissue antigens—platelet APA 71109
Antibodies to—tissue antigens—PM‑Sc1 PM1 71119
Antibodies to—tissue antigens—reticulin RCA 71119
Antibodies to—tissue antigens—salivary gland ASG 71109
Antibodies to—tissue antigens—Scl‑70 SCL 71119
Antibodies to—tissue antigens—skeletal muscle SLA 71109
Antibodies to—tissue antigens—skin basement membrane SKA 71109
Antibodies to—tissue antigens—smooth muscle SMA 71119
Antibodies to—tissue antigens—thyroglobulin ATG 71109
Antibodies to—tissue antigens—thyroid microsome TMA 71109
Antibodies to—tissue antigens—TSH receptor antibody test TSHA 71109
Antibody testing, microbial (See Microbial)
Antigen testing, microbial (See Microbial)
Antithrombin III ATH 65037
Anus—cytology on specimens from SMCY 73043
Apolipoprotein B/A1 ratio APO 66317
Arginine infusion ARIN 66297
Arsenic AS 66277
Aspartate aminotransferase AST 66201
Aspergillus—microbial antibody testing ASP 69229
Avian precipitins (bird fancier’s disease)—microbial antibody testing APP 69229
B12 vitamin RCF 66267
Barbiturate BARB 66235
Beryllium BE 66277
Beta‑hydroxybutyrate BHYB 66367
Beta‑2‑microglobulin BMIC 66361
Bicarbonate HCO3 66201
Bilirubin (all fractions) BILI 66201
Bilirubin (all fractions)—in urine UBIL 66213
Bilirubin (all fractions)—neonatal BILN 66365
Bird fancier’s disease (Avian precipitins)—microbial antibody testing APP 69229
Blastomyces—microbial antibody testing BLM 69229
Bleeding time BT 65029
Blood—compatibility testing XMAT 65023
Blood—culture BC 69215
Blood—film BF 65005
Blood—full examination FBE 65001
Blood—gases GAS 66225
Blood—group and blood group antibodies BGAB 65021
Blood—group antibodies BGA 65025
Blood—group systems BGS 65019
Blood—grouping‑ABO and RH (D antigen) BG 65017
Blood—viscosity VISC 65001
Body cavities—aspirations of—microscopy and culture of material from MCS3 69209
Body fluids—cytology BFCY 73045
Bone marrow examination—aspirate BMEA 65015
Bone marrow examination—trephine BMET 65013
Bordetella pertussis—microbial antibody testing BOR 69229
Borrelia burgdorferi—microbial antibody testing BOB 69229
Breath hydrogen test BHT 66283
Bromide BRMD 66235
Brucella—microbial antibody testing BRU 69229
C‑l esterase inhibitor—quantitative CEIQ 66257
C‑l esterase inhibitor—functional CEIF 66258
C‑Peptide CPEP 66391
C‑reactive protein CRP 65001
CA‑15.3 antigen CA15 66261
CA‑l9.9 antigen CA19 66261
CA‑125 antigen C125 66261
Cadmium CD 66277
Caeruloplasmin CPLS 66361
Calcitonin CALT 66391
Calcium (total, dialysed or ionized) CA 66201
Calculus analysis CALC 66229
Campylobacter jejuni—microbial antibody testing CAM 69229
Candida—microbial antibody testing CAN 69229
Carbamazepine (Tegretol) CARB 66235
Carboxyhaemoglobin COHB 65027
Carcinoembryonic antigen CEA 66261
Cardiac enzymes (see group tests) CE 66205
Cardiolipin—tissue antigens—antibodies ACL 71109
Catecholamines CAT 66281
Cell mediated immunity—delayed type—hypersensitivity test CMI 71137
Centromere—tissue antigens—antibodies ACA 71119
Cervix—cytology—routine CCR 73053
Cervix—cytology—abnormalities CCRA 73055
Cervix—microscopy and culture of material from MCS2 69207
Characterisation of antibodies if positive ENA ENAP 71103
Chemicals, toxic (ingested or absorbed)—assays DRGO 66231
Chlamydia—direct detection from clinical material CHLY 69221
Chlamydia—investigation by cultural methods CHLC 69261
Chlamydia—investigation by DNA probe CHLP 69261
Chlamydia—microbial antibody testing CHL 69229
Chlamydia—microbial antigen testing CHLY 69221
Chloral hydrate CHHY 66235
Chlorazepate CHZP 66235
Chloride CL 66201
Chloroquine CLOQ 66235
Chlorpromazine CHLO 66235
Cholesterol CHOL 66331
Cholesterol—HDL HDLC 66317
Cholinesterase CHSE 66367
Chorionic gonadotrophin—for pregnancy diagnosis HCG 73527
Chorionic gonadotrophin—for diagnosis of specified conditions HCGD 73529
Chorionic gonadotrophin—for Down syndrome/neural tube defect testing NTDD 66321
Chromium CR 66277
Chromosome identification and banding 73287-89
Chromosome identification—studies—blood CSB 73289
Chromosome identification—studies—other than blood CS 73287
Cimetidine CMTD 66235
Clobazam CLOB 66235
Clomipramine CLOM 66235
Clonazepam (Rivotril) CLON 66235
Clostridium difficile—microbial antigen testing CLDT 69219
Coagulation—factors (see individual factors)
Coagulation—studies (see group tests) COAG 65035
Coagulation—time CT 65029
Coccidioides—microbial antibody testing CCC 69229
Cold agglutinins CAG 65005, 65027
Collection of specimen(s) for cytological examination 73051
Compatibility testing XMAT 65023
Complement, total haemolytic COM 71081
Complement, total haemolytic—components C3 C3 71083
Complement, total haemolytic—components C4 C4 71083
Complement, total haemolytic—properdin factor B PFB 71083
Complement, total haemolytic—other components COMP 71089
Copper CU 66277
Cortisol CORT 66391
Coxsackie B1‑6—microbial antibody testing COX 69229
Creatine kinase CK 66201
Creatine kinase—isoenzymes CKI 66201
Creatine kinase—isoenzymes (electrophoresis) CKIE 66245
Creatinine C 66201
Cryofibrinogen—qualitative CFID 66213
Cryofibrinogen—quantitative CFIE 66215
Cryoglobulins—qualitative CGLD 66213
Cryoglobulins—quantitative CGLE 66215
Cryoglobulins—investigation by immunoelectrophoresis or immunofixation RYO 71061
Cryptococcal antigen—microbial antigen testing CRYN 69219
Cryptococcus—microbial antibody testing CRY 69229
CSF—microscopy and culture of material from MCS3 69209
CSF antigens—group B streptococcus STB 69219
CSF antigens—Haemophilus influenzae HI 69219
CSF antigens—Neisseria meningitidis NMG 69219
CSF antigens—Streptoccus pneumoniae SPN 69219
Cultural examination of faeces FCS 69211
Cyclic AMP CAMP 66391
Cyclosporin A CLSA 66235
Cystine—qualitative UCYS 66213
Cystine—quantitative CYST 66367
Cytology—from body fluids, sputum (1 specimen), urine, washings or brushings BFCY 73045
Cytology—from cervix‑ routine CCR 73053
Cytology—from cervix—abnormalities CCRA 73055
Cytology—from fine needle aspiration of solid tissues FNCY 73049
Cytology—from fine needle aspiration of solid tissues—asp. or attendance by a pathologist FNCP 73051
Cytology—from skin, nipple discharge, lip, mouth, nose or anus SMCY 73043
Cytology—from vagina CVO 73057
Cytology—from 3 sputum or urine specimens SPCY 73047
Cytomegalovirus—microbial antibody testing CMV 69229
Cytomegalovirus serology in pregnancy—microbial antibody testing CMVP 69253‑57
D‑dimer test DD 65029
D vitamin VITD 66271
Dehydroepiandrosterone sulphate (DHEAS) DHEA 66377
Dengue—microbial antibody testing DEN 69229
11-Deoxycortisol DCOR 66391
Desipramine DESI 66235
Dexamethasone DXST 66295
Dexamethasone—suppression test DEXA 66295
DHEAS (Dehydroepiandrosterone sulphate) DHEA 66377
Diazepam DIAZ 66235
Differential cell count DIFF 65005
Digoxin DIG 66235
Dihydrotesterone DHTS 66377
Diphenylhydantoin (Dilantin) DIL 66235
Diphtheria—microbial antibody testing DIP 69229
Direct Coombs test CMBS 65005, 65027
Disopyramide (Rythmodan) DISO 66235
DNA, double‑stranded antibodies DNAD 71099
DNA binding—quantitation and measurement if positive ANA ANAP 71099
Down syndrome/neural tube defects NTDD 66321
Doxepin hydrochloride DOXE 66235
Drugs—abuse treatment programme—assay DATP 66343
Drugs—inappropriate dosage—assay DRGO 66231
Drugs—therapeutic—assay (See individual drugs) 66235
(Drugs not listed must be written in full)
Dynamic function tests GHSE 66295
Ear- microscopy and culture of material from MCS1 69205
Echinococcus—microbial antibody testing ECC 69229
Echo‑coxsackie group—microbial antibody testing ECH 69229
Electrolytes (see group tests) E 66207
Electron microscopy of biopsy material EM 72807
Electrophoresis, to demonstrate—creatine kinase isoenzymes CKIE 66245
Electrophoresis, to demonstrate—lactate dehydrogenase isoenzymes LDI 66245
Electrophoresis, to demonstrate—protein classes, or paraprotein EPP1 66245
Electrophoresis, to demonstrate—protein classes or presence and amount of paraprotein classes, concurrent collection EPP2 66247
Elements (see individual elements)
Entamoeba histolytica—microbial antibody testing AMO 69229
Enzyme assays of solid tissue or tissues ENZS 66285
Epstein Barr virus—microbial antibody testing EBV 69229
Erythrocyte—assessment of haemolysis ERYH 65009
Erythrocyte—assessment of metabolic enzymes ERYM 65009
Erythrocyte—count RCC 65001
Erythrocyte—sedimentation rate ESR 65001
Ethosuximide (Zarontin) ETHO 66235
Euglobulin clot lysis time ECLT 65037
Extractable nuclear antigens—detection of antibodies to ENA 71101
Eye—microscopy and culture of material from MCS1 69205
Factor II FII 65045
Factor V FV 65045
Factor VII FVII 65045
Factor VIII VIII 65045
Factor IX FIX 65045
Factor X FX 65045
Factor XI FXI 65045
Factor XII FXII 65045
Factor XIII XIII 65045
Factor XIII deficiency test F13D 65029
Faecal fat FFAT 66283
Faecal fat—haemoglobin—chemical test FHC 66217
Faecal fat—haemoglobin—immunological test FHI 66219
Faecal fat—porphyrins—qualitative test FPR 66217
Faecal fat—reducing substances FRS 66217
Faeces—cultural examination FCS 69211
Faeces—microscopic examination for parasites OCP 69203
Fatty acids—total free—estimation TFFA 60637
Ferritin (see also Iron studies) FERR 66355
Fibrin monomer FM 65029
Fibrinogen FIB 65029
Fibrinogen—degradation products FDP 65029
Fitzgerald factor FGF 65045
Flecainide FLEC 66235
Fletcher factor FF 65045
Fluorescent treponemal antibody—absorption test (FTA‑ABS)—microbial antibody testing FTA 69229
Fluoxetine FLUX 66235
Folate—red cell RCF 66267
Follicle stimulating hormone (FSH) FSH 66377
Frozen section diagnosis of biopsy material FS 72803
Fructosamine FRUC 66201
Full blood examination FBE 65007
Gamma glutamyl transpeptidase GGT 66201
Gastric parietal cell—tissue antigens—antibodies PCA 71119
Gastrin GAST 66391
Gliadin IgA—tissue antigens—antibodies GLIA 71119
Globulin GLOB 66201
Glomerular basement membrane—tissue antigens—antibodies GBA 71109
Glucagon GLGO 66391
Glucagon stimulation test GSTC 66297
Glucose GLUC 66201
Glucose—tolerance test GTT 66201
Glycolated haemoglobin (Hb Alc) GHB 66319
Gold AU 66277
Gonadotrophin GRHS 66297
Group B streptococcus—CSF antigens STB 69219
Group B streptococcus—microbial antigen testing STB 69219
Group P9—simple basic pathology tests 73801‑11
Growth hormone GH 66391
Growth hormone—stimulation by exercise or L‑dopa GHSE 66295
Growth hormone—suppression by dexamethasone or glucose GHSG 66295
Haematocrit HCT 65001
Haemoglobin estimation HB 65001
Haemoglobin estimation—in urine UHB 66213
Haemoglobinopathy tests HMGP 65011
Haemophilus influenzae antigens HI 69219
Haemophilus influenzae—microbial antibody testing HUS 69229
Haemophilus influenzae—microbial antigen testing HI 69219
Haloperidol HALO 66235
Haptoglobins HGLB 66361
HDL cholesterol HDLC 66317
Heart—tissue antigens—antibodies AHE 71109
Heparin—cofactor II HRNC 65037
Heparin—estimation HEPR 65043
Hepatitis delta antibody—anti‑delta—microbial antibody testing HDA 69229
Hepatitis serology—acute hepatitis HEP 69247
Hepatitis serology—follow‑up of proven hepatitis B HEPB 69249
Hepatitis serology—hepatitis B serology to define immune status HEP1 69245
Hepatitis serology—hepatitis B surface antigen HBsAg HBSA 69243
Hepatitis serology—hepatitis C HEPC 69265
Hepatitis serology—hepatitis delta antibody HDA 69229
Hepatitis serology—in pregnancy HEPP 69253‑57
Herpes simplex virus—direct detection from clinical material HSV 69223
Herpes simplex virus—investigation by cultural methods HSVC 69263
Herpes simplex virus—microbial antibody testing HPA 69229
Herpes simplex virus—microbial antigen testing HSV 69223
Heterophile antibodies IM 65005, 65027
HIAA (hydroxyindoleacetic acid) HIAA 66367
Histamine HIAM 66367
Histone—tissue antigens—antibodies AHI 71109
Histopathology of biopsy material HIST 72801
Histoplasma—microbial antibody testing HIP 69229
HLA typing—HLA‑B27 HLAB 71147
HLA typing—HLA class 1 HLA1 71149
HLA typing—HLA class 2 HLA2 71151
HMMA (hydroxy‑3‑methoxymandelic acid previously known as VMA) HMMA 66281
HMPG (hydroxy methoxy phenylethylene glycol) HMPG 66281
Homovanillic acid HVA 66281
Hormone receptor assay—breast HRA 66315
Hormone receptor assay—ovary HRO 66315
Hormones—adrenocorticotrophic ACTH 66391
Hormones—aldosterone ALDS 66391
Hormones—androstanedione ANDR 66377
Hormones—C‑Peptide CPEP 66391
Hormones—calcitonin CALT 66391
Hormones—cortisol CORT 66391
Hormones—cyclic AMP CAMP 66391
Hormones—dehydroepiandrosterone sulphate DHEA 66377
Hormones—dihydrotestosterone DHTS 66377
Hormones—follicle stimulating hormone FSH 66377
Hormones—gastrin GAST 66391
Hormones—glucagon GLGO 66391
Hormones—gonadotrophin GRHS 66297
Hormones—growth hormone GH 66391
Hormones—growth hormone—stimulation by exercise or L‑dopa GHSE 66295
Hormones—growth hormone—suppression by dexamethasone or glucose GHSG 66295
Hormones—hormone receptor assay—breast HRA 66315
Hormones—hormone receptor assay—ovary HRO 66315
Hormones—human chorionic gonadotrophin—for pregnancy diagnosis HCG 73527
Hormones—human chorionic gonadotrophin—for diagnosis of specified conditions HCGD 73529
Hormones—human chorionic gonadotrophin—for Down syndrome/neural tube defect testing NTDD 66321
Hormones—human placental lactogen HPL 66373
Hormones—hydroxyprogesterone OHP 66377
Hormones—insulin INS 66391
Hormones—insulin, hypoglycaemia test INHY 66297
Hormones—luteinizing hormone LH 66377
Hormones—oestradiol E2 66377
Hormones—oestriol E3 66373
Hormones—oestrone E1 66377
Hormones—parathyroid hormone PTH 66391
Hormones—pentagastrin PSTR 66297
Hormones—progesterone PROG 66377
Hormones—prolactin PROL 66377
Hormones—renin REN 66391
Hormones—sex hormone binding globulin SHBG 66377
Hormones—somatomedin SOMA 66391
Hormones—testosterone TES 66377
Hormones—thyroid stimulating hormone (where not requested as part of TFTs) TSH 66371, 66377
Hormones—urine steroid fraction or fractions USF 66391
Hormones—vasoactive intestinal peptide VIP 66391
Hormones—vasopressin ADH 66391
Hormones—11 deoxycortisol DCOR 66391
Hormones and hormone binding proteins (See individual hormones and proteins) 66377, 66391
Huhner’s test HT 73521
Human chorionic gonadotrophin—for pregnancy diagnosis HCG 73527
Human chorionic gonadotrophin—for diagnosis of specified conditions HCGD 73529
Human chorionic gonadotrophin—for Down syndrome/neural tube defect testing NTDD 66321
Human placental lactogen HPL 66373
HVA (homovanillic acid) HVA 66281
Hydatid—microbial antibody testing HYD 69229
Hydroxy methoxy phenylethylene glycol HMPG 66281
Hydroxy‑3‑methoxymandelic acid previously known as VMA) HMMA 66281
Hydroxychloroquine HOCQ 66235
Hydroxyindoleacetic acid HIAA 66367
Hydroxyprogesterone OHP 66377
Hydroxyproline HYDP 66367
Imipramine IMIP 66235
Immediate frozen section diagnosis of biopsy material FS 72803
Immunoglobulins—A IGA 71067
Immunoglobulins—D IGD 71067
Immunoglobulins—E (total) IGE 71075‑79
Immunoglobulins—G IGG 71067
Immunoglobulins—G, 4 subclasses SIGG 71073
Immunoglobulins—M IGM 71067
Immunohistochemical investigation of biopsy material HIS 72805
Infectious mononucleosis IM 69229
Influenza A—microbial antibody testing FLA 69229
Influenza B—microbial antibody testing FLB 69229
Insulin INS 66391
Insulin—hypoglycaemia test INHY 66297
Insulin—tissue antigens—antibodies AINS 71109
Insulin receptor antibodies—tissue antigens—antibodies INSA 71109
Intercellular cement substance of skin—tissue antigens—antibodies ICCS 71109
Intestinal disaccharidases INTD 66283
Intrinsic factor—tissue antigens—antibodies AIF 71109
Iron studies (iron, transferrin and ferritin) IS 66263
Islet cell—tissue antigens—antibodies AIC 71109
Jo‑1—tissue antigens—antibodies JO1 71119
Keratin—tissue antigens—antibodies KERA 71119
L‑dopa GHLD 66295
Lactate LACT 66367
Lactate—dehydrogenase LDH 66201
Lactate—dehydrogenase isoenzymes LDI 66245
Lamellar body phospholipid LBPH 66243
Lead PB 66279
Lecithin/sphingomyelin ratio (amniotic fluid) LS 66243
Legionella pneumophila—serogroup 1—microbial antibody testing LP1 69229
Legionella pneumophila—serogroup 2—microbial antibody testing LP2 69229
Leishmaniasis—microbial antibody testing LEI 69229
Leptospira—microbial antibody testing LEP 69229
Leucocyte count WCC 65001
Leucocyte—3 surface markers—blood, CSF, serous fluid LMH3 71139
Leucocyte—3 surface markers—tissue LMT3 71141
Leucocyte—6 surface markers—blood, CSF, serous fluid or tissue LM6 71143
Leucocyte—6 surface markers—blood, CSF, serous fluid and tissue (s) LMHT 71145
Lignocaine LIGN 66235
Lip—cytology on specimens from SMCY 73043
Lipase LIP 66201
Lipid studies (see group tests) FATS 66331
Lipoprotein electrophoresis LEPG 66245
Listeria—microbial antibody testing LIS 69229
Lithium LI 66201
Liver function tests (see group tests) LFT 66211
Liver/kidney microsomes—tissue antigens—antibodies LKA 71119
Lupus anticoagulant LUPA 65037
Luteinising hormone LH 66377
Lymphocyte—tissue antigens—antibodies ALY 71109
Lymphocytes—functional tests—1 estimation LF1 71127
Lymphocytes—functional tests—2 estimations LF2 71129
Lymphocytes—functional tests—3 estimations LF3 71131
Magnesium MG 66201
Mammary serum antigen MSA 66261
Manganese MN 66277
Mantoux test MANT 73811
Measles—microbial antibody testing MEA 69229
Melanogen (see Urine melanin) UML 66213
Mercury HG 66277
Metalbumin detection (Schumm’s test) SCHM 65027
Metanephrines MNEP 66281
Methadone MTDN 66235
Methotrexate MTTA 66235
Methsuximide MSUX 66235
Metronidazole MRDZ 66235
Mexiletine (Mexitil) MEX 66235
Mianserin MIAS 66235
Microalbumin MALB 66361
Microbial antibody testing—actinomycetes ACT 69229
Microbial antibody testing—adenovirus ADE 69229
Microbial antibody testing—aspergillus ASP 69229
Microbial antibody testing—avian precipitins (bird fancier’s disease) APP 69229
Microbial antibody testing—Blastomyces BLM 69229
Microbial antibody testing—Bordetella pertussis BOR 69229
Microbial antibody testing—Borrelia burgdorferi BOB 69229
Microbial antibody testing—Brucella BRU 69229
Microbial antibody testing—Campylobacter jejuni CAM 69229
Microbial antibody testing—Candida CAN 69229
Microbial antibody testing—Chlamydia CHL 69229
Microbial antibody testing—Coccidioides CCC 69229
Microbial antibody testing—Coxsackie B1‑6 COX 69229
Microbial antibody testing—cryptococcus CRY 69229
Microbial antibody testing—cytomegalovirus CMV 69229
Microbial antibody testing—cytomegalovirus serology in pregnancy CMVP 69253‑57
Microbial antibody testing—dengue DEN 69229
Microbial antibody testing—diphtheria DIP 69229
Microbial antibody testing—echinococcus ECC 69299
Microbial antibody testing—echo‑coxsackie group ECH 69229
Microbial antibody testing—Entamoeba histolytica AMO 69229
Microbial antibody testing—Epstein Barr virus EBV 69229
Microbial antibody testing—fluorescent treponemal antibody—absorption test (FTA‑ABS) FTA 69229
Microbial antibody testing—Haemophilus influenzae HUS 69229
Microbial antibody testing—hepatitis C HEPC 69265
Microbial antibody testing—hepatitis delta antibody—anti‑delta HDA 69229
Microbial antibody testing—herpes HPA 69229
Microbial antibody testing—Histoplasma HIP 69229
Microbial antibody testing—hydatid HYD 69229
Microbial antibody testing—infectious mononucleosis IM 69229
Microbial antibody testing—influenza A FLA 69229
Microbial antibody testing—influenza B FLB 69229
Microbial antibody testing—Legionella pneumophila—serogroup 1 LP1 69229
Microbial antibody testing—Legionella pneumophila—serogroup 2 LP2 69229
Microbial antibody testing—leishmaniasis LEI 69229
Microbial antibody testing—Leptospira LEP 69229
Microbial antibody testing—Listeria LIS 69229
Microbial antibody testing—measles MEA 69229
Microbial antibody testing—Micropolyspora faeni MIC 69229
Microbial antibody testing—mumps MUM 69229
Microbial antibody testing—Murray Valley encephalitis MVE 69229
Microbial antibody testing—Mycoplasma pneumoniae MYC 69229
Microbial antibody testing—Neisseria menigitidis MEN 69229
Microbial antibody testing—Newcastle disease NCD 69229
Microbial antibody testing—parainfluenza 1 PF1 69229
Microbial antibody testing—parainfluenza 2 PF2 69229
Microbial antibody testing—parainfluenza 3 PF3 69229
Microbial antibody testing—paratyphi PTY 69229
Microbial antibody testing—pertussis PER 69229
Microbial antibody testing—poliomyelitis PLO 69229
Microbial antibody testing—Proteus OX 19 POX 69229
Microbial antibody testing—Proteus OXK POK 69229
Microbial antibody testing—Q fever QFF 69229
Microbial antibody testing—rapid plasma reagin test RPR 69229
Microbial antibody testing—respiratory syncytial virus RSV 69229
Microbial antibody testing—Ross River virus RRV 69229
Microbial antibody testing—rubella RUB 69229
Microbial antibody testing—Salmonella typhi (H) SAH 69229
Microbial antibody testing—Salmonella typhi (O) SAO 69229
Microbial antibody testing—Schistosoma STO 69229
Microbial antibody testing—streptococcal serology—anti‑DNASE B titre ADNB 69229
Microbial antibody testing—streptococcal serology—anti‑streptolysin O titre ASOT 69229
Microbial antibody testing—Streptococcus pneumoniae PCC 69229
Microbial antibody testing—tetanus TET 69229
Microbial antibody testing—Thermoactinomyces vulgaris THE 69229
Microbial antibody testing—thermopolyspora TPS 69229
Microbial antibody testing—Toxocara TOC 69229
Microbial antibody testing—toxoplasma TOX 69229
Microbial antibody testing—TPHA (Treponema pallidum haemagglutination test) TPHA 69229
Microbial antibody testing—Treponema pallidum haemagglutination test TPHA 69229
Microbial antibody testing—trichinosis TOS 69229
Microbial antibody testing—typhus, Weil‑Felix TYP 69229
Microbial antibody testing—Varicella zoster VCZ 69229
Microbial antibody testing—VDRL (Venereal Disease Research Laboratory) VDRL 69229
Microbial antibody testing—Yersinia enterocolitica YER 69229
Microbial antigen testing—Chlamydia CHLY 69221
Microbial antigen testing—Clostridium difficile CLDT 69219
Microbial antigen testing—group B streptococcus STB 69219
Microbial antigen testing—Haemophilus influenzae HI 69219
Microbial antigen testing—herpes simplex virus HSV 69263
Microbial antigen testing—Neisseria gonorrhoeae GON 69219
Microbial antigen testing—Neisseria meningitidis NMG 69219
Microbial antigen testing—respiratory syncytial virus RSVN 69219
Microbial antigen testing—Streptococcus pneumoniae SPN 69219
Microbial antigen testing—Varicella zoster VCZN 69219
Micropolyspora faeni MIC 69229
Microscopic examination of—faeces for parasites OCP 69203
Microscopic examination of—material other than blood M 69201
Microscopy and culture of—material from nose, throat, eye or ear MCS1 69205
Microscopy and culture of—material from skin, superficial sites, urethra, vagina, cervix or rectum MCS2 69207
Microscopy and culture of—post‑op wounds, aspirations of body cavities, synovial fluid, CSF and op/biopsy specimens MCS3 69209
Microscopy and culture of—specimens of sputum MCS2 69207
Microscopy and culture of—specimens of sputum, urine or other body fluids for mycobacteria AFB 69213
Microscopy, culture, identification and sensitivity of urine UMCS 69217
Mitochondria—tissue antigens—antibodies MA 71119
Mouth—cytology on specimens from SMCY 73043
Mucin‑like carcinoma associated antigen MCA1 66261
Mumps—microbial antibody testing MUM 69229
Murray Valley encephalitis- microbial antibody testing MVE 69229
Mycobacteria microscopy and culture of sputum AFB 69213
Mycoplasma pneumoniae—microbial antibody testing MYC 69229
Myoglobin in urine UMY 66213
N‑acetyl procainamide NAPC 66235
Neisseria gonorrhoeae—microbial antigen testing GON 69219
Neisseria menigitidis antigens NMG 69219
Neisseria menigitidis—microbial antibody testing MEN 69229
Neisseria menigitidis—microbial antigen testing NMG 69219
Neural tube defects/Down syndrome NTDD 66321
Neuron—tissue antigens—antibodies ANE 71109
Neuron specific enolase NSEN 66261
Neutrophil cytoplasm—tissue antigens—antibodies ANCA 71109
Neutrophil functions NFT 71135
Newcastle disease—microbial antibody testing NCD 69229
Nickel NI 66277
Nipple discharge—cytology on specimens from SMCY 73043
Nitrazepam NITR 66235
Nordothiepin NDIP 66235
Norfluoxetine NFLE 66235
Nortriptyline NORT 66235
Nose—cytology on specimens from SMCY 73043
Nose—microscopy and culture of material MCS1 69205
Nuclear antigens—detection of antibodies to ANA 71097
Oestradiol E2 66377
Oestriol E3 66373
Oestriol—for Down syndrome /neural tube defect testing NTDD 66321
Oestrone E1 66377
Oligoclonal proteins OGP 71065
Op/biopsy specimens—microscopy and culture of material from MCS3 69209
Osmolality, serum or urine OSML 66223
Ovary—tissue antigens—antibodies AOV 71109
Oxalate OXAL 66367
Oxazepam OXAZ 66235
PAA (phenyl acetic acid) PAA 66281
Palmitic acid in amniotic fluid PALM 66243
Pap smear CCR 73053
Papanicolaou test CCR 73053
Paracetamol PARA 66235
Parainfluenza 1—microbial antibody testing PF1 69229
Parainfluenza 2—microbial antibody testing PF2 69229
Parainfluenza 3—microbial antibody testing PF3 69229
Paraprotein investigation—by electrophoresis EPPI 66245
Paraprotein investigation—by immunoelectrophoresis or immunofixation PPRO 71061
Paraprotein investigation—on concurrently collected serum or urine PPSU 71063
Paraquat PARQ 66235
Parasites—microscopic examination of faeces OCP 69203
Parathyroid hormone (PTH) PTH 66391
Parathyroid—tissue antigens—antibodies PTHA 71109
Paratyphi—microbial antibody testing PTY 69229
Partial thromboplastin time PTT 65029
Passovy factor PF 65045
Patient episode initiation fees PEI 73901‑15
Pentagastrin PSTR 66297
Pentobarbitone PENT 66235
Perhexiline PHEX 66235
Pertussis—microbial antibody testing PER 69229
pH measurement of body fluids other than urine PH 66213
Phenobarbitone PHBA 66235
Phensuximide PHEN 66235
Phenylacetic acid PAA 66281
Phenytoin PHEY 66235
Phosphate PHOS 66201
Phosphatidylglycerol PTGL 66243
Plasminogen PLAS 65037
Platelet—aggregation PLTG 65041
Platelet—count PLTC 65001
Platelet—tissue antigens—antibodies APA 71109
PM‑Sc1—tissue antigens—antibodies PM1 71119
Poliomyelitis—microbial antibody testing PLO 69229
Porphobilingen in urine UPG 66213
Porphyrins—quantitative test, 1 or more fractions PR 66281
Porphyrins in urine—qualitative test UPR 66213
Potassium K 66201
Prealbumin PALB 66361
Prednisolone PRED 66235
Pregnancy serology—1 estimation MSP1 69253
Pregnancy serology—2 estimations MSP2 69255
Pregnancy serology—3 estimations MSP3 69257
Pregnancy testing 73805
Pregnancy testing—diagnosis HCG 73527
Pregnancy testing—diagnosis of specified conditions HCGD 73529
Pregnancy testing—diagnosis for Down syndrome/neural tube defect NTDD 66321
Primidone PRIM 66235
Procainamide PCAM 66235
Progesterone PROG 66377
Prolactin PROL 66377
Prominal PROM 66235
Propranolol PPNO 66235
Prostate specific antigen PSA 66357
Prostatic acid phosphatase ACP 66357
Protein—C PROC 65037
Protein—S PROS 65037
Protein—quantitative estimation of—alpha fetoprotein AFP 66353
Protein—quantitative estimation of—alpha fetoprotein—for Down syndrome/neural tube defect testing NTDD 66321
Protein—quantitative estimation of—alpha‑l‑antitrypsin AAT 66255
Protein—quantitative estimation of—alpha‑2‑macroglobulin AMAC 66255
Protein—quantitative estimation of—beta‑2‑microglobulin BMIC 66361
Protein—quantitative estimation of—C‑l esterase inhibitor CEI 66257
Protein—quantitative estimation of—caeruloplasmin CPLS 66361
Protein—quantitative estimation of—classes by electrophoresis EPPI 66245
Protein—quantitative estimation of—ferritin (see also Iron studies) FERR 66355
Protein—quantitative estimation of—haptoglobins HGLB 66361
Protein—quantitative estimation of—microalbumin MALB 66361
Protein, total—quantitative estimation of PROT 66201
Proteus OX 19—microbial antibody testing POX 69229
Proteus OXK—microbial antibody testing POK 69229
Prothrombin time PT 65029
Pyruvate PVTE 66367
Q fever—microbial antibody testing QFF 69229
Quinalbarb QUIB 66235
Quinidine QUIN 66235
Quinine QNN 66235
Rapid plasma reagin test—microbial antibody testing RPR 69229
RAST RAST 71079
Rectum—microscopy and culture of material from MCS2 69207
Red cell folate and serum B12 and serum folate if required RCF 66267
Red cell porphyrins—qualitative test RCP 65027
Referred specimen fee 73921
Renin REN 66391
Respiratory syncytial virus—microbial antibody testing RSV 69229
Respiratory syncytial virus—microbial antigen testing RSVN 69219
Reticulin—tissue antigens—antibodies RCA 71119
Reticulocyte count RETC 65001
Rheumatoid factor RF 71105
Rheumatoid factor—quantitation RFQ 71107
Ross River virus—microbial antibody testing RRV 69229
RSV—respiratory syncytial virus—microbial antigen testing RSVN 69219
RSV—respiratory syncytial virus—microbial antibody testing RSV 69229
Rubella—serology RUB 69229
Salicylate—aspirin SALI 66235
Salivary gland—tissue antigens—antibodies ASG 71109
Salmonella typhi (H)—microbial antibody testing SAH 69229
Salmonella typhi (O)—microbial antibody testing SAO 69229
Schistosoma—microbial antibody testing STO 69229
Scl‑70—tissue antigens—antibodies SCL 71119
Secretin SSGR 66297
Selenium SE 66277
Semen examination SEE 73523
Semen examination—for spermatozoa (post vasectomy) SES 73521
Serology—in pregnancy (see Pregnancy serology)
Serotonin 5HT 66367
Serum—Bl2 B12 66265
Serum—folate (with Bl2) FOL 66265
Serum—folate (with Bl2 red cell folate) RCF 66267
Sex hormone binding globulin SHBG 66377
Skeletal muscle—tissue antigens—antibodies SLA 71109
Skin—cytology SMCY 73043
Skin—microscopy and culture of material from MCS2 69207
Skin basement membrane—tissue antigens—antibodies SKA 71109
Snake venom HISS 66231
Smooth muscle—tissue antigens—antibodies SMA 71119
Sodium NA 66201
Solid tissue or tissues—chemical assays ENZS 66285
Solid tissue or tissues—cytology of fine needle aspiration FNCY 73049
Solid tissue or tissues—cytology of fine needle aspiration by, or in presence of pathologist FNCP 73051
Somatomedin SOMA 66391
Sotalol SALL 66235
Specific IgG or IgE antibodies RAST 71079
Specimen referred fee 73921
Sperm antibodies SAB 73525
Sperm antibodies—penetrating ability SPA 73525
Sputum—cytology (1 specimen) BFCY 73045
Sputum—cytology (3 specimens) SPCY 73047
Sputum—microscopy and culture of specimens MCS2 69207
Sputum—for mycobacteria AFB 69213
Stelazine STEL 66235
Steroid fraction or fractions in urine USF 66391
Streptococcal serology—anti‑DNASE B titre—microbial antibody testing ADNB 69229
Streptococcal serology—anti‑streptolysin O titre—microbial antibody testing ASOT 69229
Streptococcus—Group B STB 69219
Streptococcus pneumoniae—antigens SPN 69219
Streptococcus pneumoniae—microbial antibody testing PCC 69229
Streptococcus pneumoniae—microbial antigen testing SPN 69219
Strontium SR 66277
Sulthiame (Ospolot) SUL 66235
Synacthen stimulation test SYNS 66297
Syphilis serology (see group tests) STS 69231
Testosterone TES 66377
Tetanus—microbial antibody testing TET 69229
Thalassaemia studies TS 65011
Theophylline THEO 66235
(Therapeutic drugs must be written in full)
Thermoactinomyces vulgaris—microbial antibody testing THE 69229
Thermopolyspora—microbial antibody testing TPS 69229
Thiopentone TOPO 66235
Thioridazine THIO 66235
Throat—microscopy and culture of material from MCS1 69205
Thrombin time TT 65029
Thyroglobulin TGL 66261
Thyroglobulin—tissue antigens—antibodies ATG 71109
Thyroid—function tests TFT 66291
Thyroid—stimulating hormone (where not requested as part of TFTs) TSH 66371, 66377
Thyroid microsome—tissue antigens—antibodies TMA 71109
Thyrotrophin releasing hormone test TRH 66293
(Tissue antigens which are not listed must be written in full)
Total free fatty acids TFFA 66367
Total protein PROT 66201
Toxocara—microbial antibody testing TOC 69229
Toxoplasma—microbial antibody testing TOX 69229
TPHA (Treponema pallidum haemagglutination test)—microbial antibody testing TPHA 69229
Treponema pallidum haemagglutination test—microbial antibody testing TPHA 69229
Trichinosis—microbial antibody testing TOS 69229
Triglycerides TRIG 66331
Trimipramine TRIM 66235
Tryptic activity in faeces TAF 66323
TSH receptor antibody test—tissue antigens—antibodies TSHA 71109
TSH (where not requested as part of a thyroid function test) TSH 66371, 66377
Tumour markers—CA‑15.3 antigen CA15 66261
Tumour markers—CA‑19.9 antigen CA19 66261
Tumour markers—CA‑125 antigen C125 66261
Tumour markers—carcinoembryonic antigen CEA 66261
Tumour markers—mammary serum antigen MSA 66261
Tumour markers—mucin‑like carcinoma associated antigen MCA 66261
Tumour markers—neuron specific enolase NSEN 66261
Tumour markers—prostate specific antigen PSA 66357
Tumour markers—prostatic acid phosphatase‑1 or more fractions ACP 66357
Tumour markers—thyroglobulin TGL 66261
Typhus, Weil‑Felix—microbial antibody testing TYP 69229
Urate URAT 66201
Urea U 66201
Urea, electrolytes, creatinine (see group tests) U&E 66211
Urethra—microscopy and culture of material from MCS2 69207
Urine—bilirubin UBIL 66213
Urine—catalase test 73805
Urine—cytology—on 1 specimen BFCY 73045
Urine—cytology—on 3 specimens SPCY 73047
Urine—cystine (cysteine) UCYS 66213
Urine—haemoglobin UHB 66213
Urine—melanin (melanogen) UML 66213
Urine—microscopy, culture, identification and sensitivity UMCS 69217
Urine—myoglobin UMY 66213
Urine—porphobilinogen UPG 66213
Urine—porphyrins—qualitative test UPR 66213
Urine—steroid fraction or fractions USF 66391
Urine—urobilinogen UUB 66213
Vagina—cytology on specimens from CVO 73057
Vagina—microscopy and culture of material from MCS2 69207
Valproate (Epilim) VALP 66235
Vancomycin VAN 66235
Varicella zoster—microbial antibody testing VCZ 69229
Varicella zoster—microbial antigen testing VCZN 69219
Vasoactive intestinal peptide VIP 66391
Vasopressin ADH 66391
VDRL (Venereal Disease Research Laboratory)—microbial antibody testing VDRL 69229
Viscosity of blood or plasma VISC 65001
Vitamins—B12 RCF 66267
Vitamins—D VITD 66271
Vitamins—folate RCF 66267
Vitamins—quantitative estimation of A, B1, B2, B3, B6, C or E VIT 66269
VMA (see HMMA)
Von Willebrand’s factor VWF 65045
Von Willebrand’s factor antigen VWA 65045
Warfarin WFR 66235
Xylose XYL 66367
Yersinia enterocolitica—microbial antibody testing YER 69229
Zinc ZN 66367
____________________________________________________________
NOTE
1. Notified in the Commonwealth of Australia Gazette on 1 November 1993.
